{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T18:47:25Z","timestamp":1775933245756,"version":"3.50.1"},"posted":{"date-parts":[[2025,2,27]]},"group-title":"Cancer Biology","reference-count":48,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,2,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Patients with myeloid neoplasms with loss-of-function\n                  <jats:italic>TP53<\/jats:italic>\n                  mutations and erythroid differentiation have poor outcomes, and a better understanding of disease biology is required. Upregulation of interferon-\u03b3 (IFN-\u03b3) signaling has been associated with acute myeloid leukemia (AML) progression and chemotherapy resistance, but its drivers remain unclear. In this study, we found that the surface receptor C-C motif chemokine receptor-like 2 (CCRL2) is overexpressed in AML with erythroid differentiation and\n                  <jats:italic>TP53<\/jats:italic>\n                  mutations compared to other AML subtypes and healthy hematopoietic cells. The knockout (KO) of CCRL2 suppressed erythroleukemia growth\n                  <jats:italic>in vitro<\/jats:italic>\n                  and\n                  <jats:italic>in vivo<\/jats:italic>\n                  . Further proteomics and transcriptomics analysis revealed IFN-\u03b3 signaling response as the top CCRL2-regulated pathway in erythroleukemia. Our mechanistic studies support direct CCRL2 driven IFN-\u03b3 signaling independent of exogenous IFN-\u03b3, through phosphorylation of STAT1, via JAK2-dependent and independent mechanisms. CCRL2\/IFN-\u03b3 signaling is upregulated in erythroid leukemias, and\n                  <jats:italic>TP53<\/jats:italic>\n                  mutated AML without concurrent increase of IFN-\u03b3 secretion in the bone marrow microenvironment and is directly induced by\n                  <jats:italic>TP53<\/jats:italic>\n                  KO. Finally, CCRL2\/IFN-\u03b3 signaling is associated with the transformation of pre-leukemic single-hit\n                  <jats:italic>TP53<\/jats:italic>\n                  clones to multi-hit\n                  <jats:italic>TP53<\/jats:italic>\n                  mutated AML, increased resistance to venetoclax and worse survival in AML. Overall, our findings support that CCRL2 is an essential driver of cell-autonomous IFN-\u03b3 signaling response in myeloid neoplasms with erythroid differentiation and\n                  <jats:italic>TP53<\/jats:italic>\n                  mutations and highlight CCRL2 as a relevant novel target for these neoplasms.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>One Sentence Summary<\/jats:title>\n                  <jats:p>\n                    CCRL2 is overexpressed in AML with loss-of-function\n                    <jats:italic>TP53<\/jats:italic>\n                    mutations and erythroid differentiation and promotes IFN-\u03b3 signaling response via a cell-intrinsic mechanism.\n                  <\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.02.21.639304","type":"posted-content","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T22:30:59Z","timestamp":1740695459000},"source":"Crossref","is-referenced-by-count":2,"title":["CCRL2 promotes the interferon-\u03b3 signaling response in myeloid neoplasms with erythroid differentiation and mutated\n                  <i>TP53<\/i>"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4761-7435","authenticated-orcid":false,"given":"Nour Sabiha","family":"Naji","sequence":"first","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergiu","family":"Pasca","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Chatzilygeroudi","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Toledano-Sanz","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Rimando","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Emory University School of Medicine, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashvi","family":"Hemani","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandy","family":"Perkins","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Conover","family":"Talbot","sequence":"additional","affiliation":[{"name":"Institute for Basic Biomedical Sciences, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Paun","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmuez","family":"Abdulmalik","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Lossos","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatianna R","family":"Boronina","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilias","family":"Sinanidis","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Tsakiroglou","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Esteb","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Ambinder","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena","family":"Xian","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Gojo","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Paul","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Levis","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy E.","family":"DeZern","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Luznik","sequence":"additional","affiliation":[{"name":"Hematology-Oncology Section, Baylor College of Medicine, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Styliani","family":"Karanika","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"Resar","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Jones","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Bunz","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukasz","family":"Gondek","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marios","family":"Arvanitis","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6792-8298","authenticated-orcid":false,"given":"Theodoros","family":"Karantanos","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies and Bone Marrow Transplantation, Department of Medical Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026041111195340000_2025.02.21.639304v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"2026041111195340000_2025.02.21.639304v1.2","doi-asserted-by":"crossref","unstructured":"Almeida, A.M. , et al., Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study. Int J Mol Sci, 2017. 18(4).","DOI":"10.3390\/ijms18040837"},{"key":"2026041111195340000_2025.02.21.639304v1.3","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0332"},{"key":"2026041111195340000_2025.02.21.639304v1.4","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.280487"},{"key":"2026041111195340000_2025.02.21.639304v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00746-x"},{"issue":"7540","key":"2026041111195340000_2025.02.21.639304v1.6","first-page":"552-555","article-title":"Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia","volume":"518","year":"2015","journal-title":"Nature"},{"key":"2026041111195340000_2025.02.21.639304v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02299-y"},{"key":"2026041111195340000_2025.02.21.639304v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01480-1"},{"key":"2026041111195340000_2025.02.21.639304v1.9","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002512"},{"key":"2026041111195340000_2025.02.21.639304v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45916-6"},{"key":"2026041111195340000_2025.02.21.639304v1.11","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.615031"},{"key":"2026041111195340000_2025.02.21.639304v1.12","doi-asserted-by":"crossref","unstructured":"Karantanos, T. , et al., The role of the atypical chemokine receptor CCRL2 in myelodysplastic syndrome and secondary acute myeloid leukemia. Sci Adv, 2022. 8(7): p. eabl8952.","DOI":"10.1126\/sciadv.abl8952"},{"issue":"7","key":"2026041111195340000_2025.02.21.639304v1.13","first-page":"1886","article-title":"CCRL2 aZects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine","volume":"108","year":"2023","journal-title":"Haematologica"},{"key":"2026041111195340000_2025.02.21.639304v1.14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1101"},{"issue":"7728","key":"2026041111195340000_2025.02.21.639304v1.15","first-page":"526-531","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","year":"2018","journal-title":"Nature"},{"issue":"7843","key":"2026041111195340000_2025.02.21.639304v1.16","first-page":"514-516","article-title":"Cancer research needs a better map","volume":"589","year":"2021","journal-title":"Nature"},{"key":"2026041111195340000_2025.02.21.639304v1.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1"},{"key":"2026041111195340000_2025.02.21.639304v1.18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014465"},{"key":"2026041111195340000_2025.02.21.639304v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6494"},{"key":"2026041111195340000_2025.02.21.639304v1.20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27883"},{"key":"2026041111195340000_2025.02.21.639304v1.21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102"},{"key":"2026041111195340000_2025.02.21.639304v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2005.02.021"},{"key":"2026041111195340000_2025.02.21.639304v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/nri3581"},{"key":"2026041111195340000_2025.02.21.639304v1.24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M105070200"},{"key":"2026041111195340000_2025.02.21.639304v1.25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.24.13956"},{"key":"2026041111195340000_2025.02.21.639304v1.26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.35.20775"},{"key":"2026041111195340000_2025.02.21.639304v1.27","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011094"},{"key":"2026041111195340000_2025.02.21.639304v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.01.031"},{"key":"2026041111195340000_2025.02.21.639304v1.29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0224"},{"key":"2026041111195340000_2025.02.21.639304v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2023.05.007"},{"key":"2026041111195340000_2025.02.21.639304v1.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0375-1"},{"key":"2026041111195340000_2025.02.21.639304v1.32","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009103"},{"key":"2026041111195340000_2025.02.21.639304v1.33","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0192"},{"key":"2026041111195340000_2025.02.21.639304v1.34","doi-asserted-by":"crossref","unstructured":"Gera, K. , et al., Survival after Pure (Acute) Erythroid Leukemia in the United States: A SEER-Based Study. Cancers (Basel), 2023. 15(15).","DOI":"10.3390\/cancers15153941"},{"key":"2026041111195340000_2025.02.21.639304v1.35","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01060-8"},{"key":"2026041111195340000_2025.02.21.639304v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2017.09.002"},{"issue":"2","key":"2026041111195340000_2025.02.21.639304v1.37","first-page":"121","article-title":"[Molecular pathogenesis and therapeutic targets in acute erythroid leukemia]","volume":"63","year":"2022","journal-title":"Rinsho Ketsueki"},{"key":"2026041111195340000_2025.02.21.639304v1.38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-777680"},{"key":"2026041111195340000_2025.02.21.639304v1.39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI136259"},{"key":"2026041111195340000_2025.02.21.639304v1.40","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010312"},{"key":"2026041111195340000_2025.02.21.639304v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(01)02118-4"},{"key":"2026041111195340000_2025.02.21.639304v1.42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-210412"},{"key":"2026041111195340000_2025.02.21.639304v1.43","doi-asserted-by":"publisher","DOI":"10.1038\/S41596-018-0082-X"},{"key":"2026041111195340000_2025.02.21.639304v1.44","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201000722"},{"key":"2026041111195340000_2025.02.21.639304v1.45","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.T500007-MCP200"},{"key":"2026041111195340000_2025.02.21.639304v1.46","doi-asserted-by":"publisher","DOI":"10.1021\/pr300624g"},{"key":"2026041111195340000_2025.02.21.639304v1.47","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018022921"},{"key":"2026041111195340000_2025.02.21.639304v1.48","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2006-0686"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.02.21.639304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T18:20:00Z","timestamp":1775931600000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.02.21.639304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":48,"URL":"https:\/\/doi.org\/10.1101\/2025.02.21.639304","relation":{},"subject":[],"published":{"date-parts":[[2025,2,27]]},"subtype":"preprint"}}